Edition:
United States

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

200.11USD
1:43pm EDT
Change (% chg)

$-2.48 (-1.22%)
Prev Close
$202.59
Open
$202.59
Day's High
$206.22
Day's Low
$198.09
Volume
99,332
Avg. Vol
120,336
52-wk High
$277.48
52-wk Low
$126.77

Chart for

About

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $5,214.76
Shares Outstanding(Mil.): 21.10
Dividend: --
Yield (%): --

Financials

  LGND.OQ Industry Sector
P/E (TTM): 38.73 119.85 32.14
EPS (TTM): 6.38 -- --
ROI: 18.57 1.96 12.83
ROE: 30.30 1.12 14.95

BRIEF-Ligand Prices Offering Of $650 Mln Of Convertible Senior Notes

* LIGAND PRICES OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES

May 18 2018

BRIEF-Ligand Pharmaceuticals Announces Proposed Offering Of $650 Mln Of Convertible Senior Notes

* LIGAND ANNOUNCES PROPOSED OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES

May 16 2018

BRIEF-Ligand Pharmaceuticals Entered Commercial Platform License Agreement, With KSQ Therapeutics

* LIGAND PHARMACEUTICALS - ON MAY 8, ENTERED COMMERCIAL PLATFORM LICENSE AGREEMENT, WITH KSQ THERAPEUTICS, INC - SEC FILING

May 10 2018

BRIEF-Ligand Reports Q1 Adjusted Earnings Per Share $1.55

* Q1 EARNINGS PER SHARE VIEW $1.15 -- THOMSON REUTERS I/B/E/S

May 08 2018

Earnings vs. Estimates